## Abstract ## Objective To examine the degree to which disease severity and domains of self‐efficacy (pain, function, and other symptoms) explain pain and functioning in rheumatoid arthritis (RA) patients. ## Methods Patients (n = 263) completed the Arthritis Impact Measurement Scales 2 to asse
Antibody to a specific HLA—DRβ1 sequence in Japanese patients with rheumatoid arthritis
✍ Scribed by Fujio Takeuchi; Eri Kosuge; Kunio Matsuta; Keiichiro Nakano; Katsushi Tokunaga; Takeo Juji; Terumasa Miyamoto
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 218 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective Cardiovascular (CV) disease is the most common cause of mortality in patients with rheumatoid arthritis (RA). We assessed the contribution of epidemiologic features, clinical features, routine laboratory markers of inflammation, and HLA–DRB1 alleles to CV mortality in pati
Objective. To compare the incidence of antidouble-stranded DNA (anti-dsDNA) antibodies in rheumatoid arthritis (RA) patients receiving either single or multiple doses of a chimeric anti-tumor necrosis factor ␣ (anti-TNF␣) antibody or placebo infusions, with or without methotrexate, in open-label, ra